Area of research
Pulmonary and Respiratory Medicine · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Idiopathic pulmonary fibrosis, Pulmonary fibrosis, Interstitial lung disease, Internal medicine, and Lung.
Oral Nalbuphine in Idiopathic Pulmonary Fibrosis–Associated Cough
International validation of electronic nose technology as a diagnostic tool for fibrotic interstitial lung diseases
Update of the International Multidisciplinary Classification of the Interstitial Pneumonias: An ERS/ATS Statement
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation
Associations of interstitial lung disease subtype and CT pattern with lung function and survival
Lower Airway and Oral Microbiome Dysbiosis in Patients with Long COVID Post-Hospitalisation: A UK Multicentre, Prospective Cohort Study
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease
Cluster analysis of blood biomarkers to identify molecular patterns in pulmonary fibrosis: assessment of a multicentre, prospective, observational cohort with independent validation
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases
Looking Beyond the Lower Airways for Microbes Affecting Pulmonary Fibrosis
Modified blood cell GAP model as a prognostic biomarker in idiopathic pulmonary fibrosis
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosis
Pulmonary fibrosis: from pathogenesis to clinical decision-making
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants
PCSK6 and Survival in Idiopathic Pulmonary Fibrosis
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
Validation of Proposed Criteria for Progressive Pulmonary Fibrosis
Therapeutic Targeting of the Respiratory Microbiome
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
Microbiome, Metabolism, and Immunoregulation of Asthma: An American Thoracic Society and National Institute of Allergy and Infectious Diseases Workshop Report
Lung function trajectory in progressive fibrosing interstitial lung disease
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells
50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study
Itaconate controls the severity of pulmonary fibrosis